Shono, Takefumi http://orcid.org/0000-0001-5614-8520
Hyakutake, Hiroyuki
Funding for this research was provided by:
Mochida Pharmaceutical Company
EA Pharma Co., Ltd.
Article History
Received: 14 March 2024
Accepted: 26 August 2024
First Online: 11 September 2024
Declarations
:
: This study was conducted after being approved by the institutional review board, Maebashi Hirosegawa Clinic (accreditation no.: 16000033). The study was registered to the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) (registration number: UMIN000049865) on 22 December 2022. This study was carried out in accordance with the principles of the Declaration of Helsinki, Ethical Guidelines for Medical and Biological Research Involving Human Subjects, and the study protocol. Informed consent was obtained in writing or by the opt-out method. Blood and feces samples for the exploratory study were collected after receiving written informed consent.
: Not applicable.
: T.S. has received funding from the following companies: Mochida Pharmaceutical Co., Ltd. and EA Pharma Co., Ltd. H.H. has no competing interests.